XML 153 R134.htm IDEA: XBRL DOCUMENT v3.25.0.1
Associates and Joint Ventures - VMED O2 UK Narrative (Details)
€ in Millions, £ in Millions
7 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
EUR (€)
Dec. 31, 2024
EUR (€)
Dec. 31, 2024
GBP (£)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
GBP (£)
Dec. 31, 2022
EUR (€)
Dec. 31, 2024
GBP (£)
Disclosure Of Joint Ventures And Associates [Line Items]                
Goodwill impairment     € 866   € 58   € 0  
Valuation assumption, discount rate (in percentage)     7.70% 7.70% 7.50% 7.50%    
Valuation assumption, perpetuity growth rate (in percentage)     1.00% 1.00%        
Period covering projected cash flows for calculation of impairment     5 years 5 years        
Valuation assumption, weighted average cost of capital, increase (decrease)     0.50%         0.50%
Valuation assumption, weighted average cost of capital, impairment of goodwill     € 2,050 £ 1,700        
Valuation assumption, perpetuity growth rate, increase (decrease)     0.25%         0.25%
Valuation assumption, increase (decrease) in EBITDA margin     1.00%         1.00%
Valuation assumption, increase (decrease) in long term investment ratio     0.50%         0.50%
Investments accounted for by the equity method     € 8,143   € 8,265      
VMO2                
Disclosure Of Joint Ventures And Associates [Line Items]                
Goodwill impairment   € 0 € 0   3,572 £ 3,107 € 0  
Proportion of ownership interest in joint venture 50.00% 50.00% 50.00% 50.00%        
Period covering projected cash flows for calculation of impairment     10 years 10 years        
Amount by which unit's recoverable amount exceeds its carrying amount     € 965         £ 800
Investments accounted for by the equity method     € 7,641   7,774      
VMO2 | Telefónica, S.A.                
Disclosure Of Joint Ventures And Associates [Line Items]                
Goodwill impairment         € 1,786      
Forecast | Minimum                
Disclosure Of Joint Ventures And Associates [Line Items]                
Valuation assumption, EBITDA margin (in percentage)     32.00% 32.00%        
Valuation assumption, long-term capital expenditure ratio (in percentage)     12.00% 12.00%        
Forecast | Maximum                
Disclosure Of Joint Ventures And Associates [Line Items]                
Valuation assumption, EBITDA margin (in percentage)     41.00% 41.00%        
Valuation assumption, long-term capital expenditure ratio (in percentage)     15.00% 15.00%